444 related articles for article (PubMed ID: 31366113)
1. Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
Mahipal A; Tella SH; Kommalapati A; Lim A; Kim R
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31366113
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date.
Tella SH; Mahipal A; Kommalapati A; Jin Z
Onco Targets Ther; 2019; 12():10335-10342. PubMed ID: 31819517
[TBL] [Abstract][Full Text] [Related]
3. Systemic targeted and immunotherapy for advanced hepatocellular carcinoma.
Cersosimo RJ
Am J Health Syst Pharm; 2021 Jan; 78(3):187-202. PubMed ID: 33211092
[TBL] [Abstract][Full Text] [Related]
4. Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions.
Weinmann A; Galle PR
Curr Oncol; 2020 Nov; 27(Suppl 3):S152-S164. PubMed ID: 33343209
[TBL] [Abstract][Full Text] [Related]
5. First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.
Tella SH; Kommalapati A; Mahipal A; Jin Z
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740326
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapy for advanced hepatocellular carcinoma: targeted therapies.
Tella SH; Kommalapati A; Mahipal A
Chin Clin Oncol; 2021 Feb; 10(1):10. PubMed ID: 32434345
[TBL] [Abstract][Full Text] [Related]
7. Locoregional and systemic therapy for hepatocellular carcinoma.
Gbolahan OB; Schacht MA; Beckley EW; LaRoche TP; O'Neil BH; Pyko M
J Gastrointest Oncol; 2017 Apr; 8(2):215-228. PubMed ID: 28480062
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G
World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options for hepatocellular carcinoma.
Eugen K
Klin Onkol; 2020; 33(Supplementum 3):20-25. PubMed ID: 33213161
[TBL] [Abstract][Full Text] [Related]
10. Review article: new therapeutic interventions for advanced hepatocellular carcinoma.
Bangaru S; Marrero JA; Singal AG
Aliment Pharmacol Ther; 2020 Jan; 51(1):78-89. PubMed ID: 31747082
[TBL] [Abstract][Full Text] [Related]
11. Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond.
Feng MY; Chan LL; Chan SL
Curr Oncol; 2022 Aug; 29(8):5489-5507. PubMed ID: 36005172
[TBL] [Abstract][Full Text] [Related]
12. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
Liu Z; Lin Y; Zhang J; Zhang Y; Li Y; Liu Z; Li Q; Luo M; Liang R; Ye J
J Exp Clin Cancer Res; 2019 Nov; 38(1):447. PubMed ID: 31684985
[TBL] [Abstract][Full Text] [Related]
13. Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence.
De Luca E; Marino D; Di Maio M
Cancer Manag Res; 2020; 12():3721-3729. PubMed ID: 32547208
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma.
Contratto M; Wu J
World J Gastrointest Oncol; 2018 May; 10(5):108-114. PubMed ID: 29770170
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment.
Siu EH; Chan AW; Chong CC; Chan SL; Lo KW; Cheung ST
Transl Gastroenterol Hepatol; 2018; 3():89. PubMed ID: 30603725
[TBL] [Abstract][Full Text] [Related]
16. Current and Future Systemic Therapies for Hepatocellular Carcinoma.
Bteich F; Di Bisceglie AM
Gastroenterol Hepatol (N Y); 2019 May; 15(5):266-272. PubMed ID: 31360140
[TBL] [Abstract][Full Text] [Related]
17. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.
Doycheva I; Thuluvath PJ
J Clin Exp Hepatol; 2019; 9(5):588-596. PubMed ID: 31695249
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapies in advanced hepatocellular carcinoma.
Medavaram S; Zhang Y
Exp Hematol Oncol; 2018; 7():17. PubMed ID: 30087805
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapies for hepatocellular carcinoma: the present and the future.
Celsa C; Giuffrida P; Stornello C; Grova M; Spatola F; Rizzo GEM; Busacca A; Cannella R; Battaglia S; Cammà C; Cabibbo G
Recenti Prog Med; 2021 Feb; 112(2):110-116. PubMed ID: 33624623
[TBL] [Abstract][Full Text] [Related]
20. A concise review of the changing landscape of hepatocellular carcinoma.
Draper A
Am J Manag Care; 2020 Oct; 26(10 Suppl):S211-S219. PubMed ID: 33052638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]